Clinical Trial Update: Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

View source ↗

Summary

This clinical trial update reports long-term follow-up to detect delayed adverse events in recipients of Cal-1 modified hematopoietic cellular products for HIV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cal-1

Snippet

Sponsor: Calimmune, Inc. | Conditions: HIV-1 Infection, Receipt of Cal-1 Modified Hematopoietic Cellular Products | Status: ACTIVE_NOT_RECRUITING